RecruitingNCT03300830
Rare condition
Castleman disease
13
studies recruiting now
as of 7 Sept 2026
47
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
28 Aug 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT00006518
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingNot applicableNCT07793006
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
RecruitingPhase 2NCT05907759
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
RecruitingNCT04968288
Natural History of KSHV-Associated Multicentric Castleman s Disease
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 13 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Castleman disease study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Castleman disease
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
1 approved treatment and 10 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Ibudilast
Phase 2Etoposide (Etoposide)
Phase 2Zanubrutinib (Brukinsa)
Phase 2Prednisone (Cortan)
Phase 2Rituximab (Blitzima)
Phase 2Thalidomide (Kevadon)
Phase 2Cyclophosphamide (Cyclophosphamide)
Phase 2Sirolimus (Fyarro)
Phase 2Nintedanib (Nintedanib component of ofev)
+ 2 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).